investorscraft@gmail.com

Intrinsic ValueAmerican Healthcare REIT, Inc. (AHR)

Previous Close$46.91
Intrinsic Value
Upside potential
Previous Close
$46.91

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

American Healthcare REIT, Inc. (AHR) operates as a real estate investment trust (REIT) specializing in healthcare-related properties, including senior housing, medical office buildings, and skilled nursing facilities. The company generates revenue primarily through long-term leases and rental income from its diversified portfolio, which serves healthcare providers and operators. AHR’s focus on essential healthcare real estate positions it in a defensive sector with stable demand, driven by demographic trends such as an aging population and increasing healthcare needs. The REIT’s market position is reinforced by its strategic acquisitions and partnerships with leading healthcare operators, ensuring occupancy stability and cash flow visibility. By maintaining a geographically diversified asset base, AHR mitigates regional economic risks while capitalizing on localized demand for healthcare services. Its business model aligns with the growing need for specialized healthcare infrastructure, offering investors exposure to a resilient niche within the broader real estate market.

Revenue Profitability And Efficiency

AHR reported revenue of $2.07 billion for FY 2024, reflecting its substantial portfolio scale. However, the company posted a net loss of $37.8 million, with diluted EPS of -$0.29, indicating margin pressures, possibly from higher operating costs or interest expenses. Operating cash flow stood at $176.1 million, suggesting core operations remain cash-generative despite profitability challenges. Capital expenditures of $91.9 million highlight ongoing investments in property maintenance and growth.

Earnings Power And Capital Efficiency

The negative net income raises questions about AHR’s near-term earnings power, though its operating cash flow demonstrates underlying cash generation capability. The REIT’s ability to cover its dividend—distributing $0.93 per share—will depend on stabilizing profitability and managing leverage. Capital efficiency metrics are not fully clear without ROIC or FFO data, but the sizable debt load suggests careful capital allocation is critical.

Balance Sheet And Financial Health

AHR’s balance sheet shows $76.7 million in cash against $1.87 billion in total debt, indicating a leveraged position. The debt-to-equity ratio is not provided, but the high absolute debt level warrants scrutiny, especially given rising interest rates. Liquidity appears manageable, with operating cash flow supporting near-term obligations, but refinancing risks may persist in a tight credit environment.

Growth Trends And Dividend Policy

Growth prospects hinge on AHR’s ability to expand its healthcare property portfolio amid competitive demand. The $0.93 per share dividend implies a yield that may appeal to income-focused investors, but sustainability depends on improving profitability and cash flow. Demographic tailwinds in healthcare demand could support long-term growth, though near-term execution risks remain.

Valuation And Market Expectations

Market expectations for AHR likely balance its sector resilience against financial leverage and earnings volatility. The REIT’s valuation will be influenced by cap rates for healthcare properties, interest rate trends, and its ability to stabilize margins. Investors may weigh its dividend yield against peers while assessing leverage-adjusted returns.

Strategic Advantages And Outlook

AHR’s strategic advantage lies in its focus on mission-critical healthcare real estate, which offers recession-resistant cash flows. The outlook depends on operational execution, debt management, and capital recycling. Success in optimizing its asset mix and lease structures could enhance long-term value, though macroeconomic and sector-specific headwinds pose risks.

Sources

Company filings (CIK: 0001632970), reported financials for FY 2024

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount